Impact Biomedical, Stock Market Value
| IBO Stock | USD 0.50 0 0.40% |
| Symbol | Impact |
Impact BioMedical, Company Valuation
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical,. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical, is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical,'s value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical,'s market value can be influenced by many factors that don't directly affect Impact BioMedical,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Impact BioMedical, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Impact BioMedical,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Impact BioMedical,.
| 10/30/2025 |
| 12/29/2025 |
If you would invest 0.00 in Impact BioMedical, on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Impact BioMedical, or generate 0.0% return on investment in Impact BioMedical, over 60 days. Impact BioMedical, is related to or competes with Estrella Immunopharma, VTv Therapeutics, Telomir Pharmaceuticals,, Fortress Biotech, ImmuCell, Mersana Therapeutics, and BioXcel Therapeutics. Impact BioMedical, is entity of United States More
Impact BioMedical, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Impact BioMedical,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Impact BioMedical, upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 61.57 | |||
| Value At Risk | (7.02) | |||
| Potential Upside | 6.82 |
Impact BioMedical, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Impact BioMedical,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Impact BioMedical,'s standard deviation. In reality, there are many statistical measures that can use Impact BioMedical, historical prices to predict the future Impact BioMedical,'s volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (1.00) | |||
| Treynor Ratio | (0.84) |
Impact BioMedical, Backtested Returns
Impact BioMedical, holds Efficiency (Sharpe) Ratio of -0.0353, which attests that the entity had a -0.0353 % return per unit of risk over the last 3 months. Impact BioMedical, exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Impact BioMedical,'s Standard Deviation of 7.05, risk adjusted performance of (0.01), and Market Risk Adjusted Performance of (0.83) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.29, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Impact BioMedical,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding Impact BioMedical, is expected to be smaller as well. At this point, Impact BioMedical, has a negative expected return of -0.25%. Please make sure to check out Impact BioMedical,'s potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Impact BioMedical, performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.3 |
Weak reverse predictability
Impact BioMedical, has weak reverse predictability. Overlapping area represents the amount of predictability between Impact BioMedical, time series from 30th of October 2025 to 29th of November 2025 and 29th of November 2025 to 29th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Impact BioMedical, price movement. The serial correlation of -0.3 indicates that nearly 30.0% of current Impact BioMedical, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.3 | |
| Spearman Rank Test | -0.43 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Impact BioMedical, lagged returns against current returns
Autocorrelation, which is Impact BioMedical, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Impact BioMedical,'s stock expected returns. We can calculate the autocorrelation of Impact BioMedical, returns to help us make a trade decision. For example, suppose you find that Impact BioMedical, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Impact BioMedical, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Impact BioMedical, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Impact BioMedical, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Impact BioMedical, stock over time.
Current vs Lagged Prices |
| Timeline |
Impact BioMedical, Lagged Returns
When evaluating Impact BioMedical,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Impact BioMedical, stock have on its future price. Impact BioMedical, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Impact BioMedical, autocorrelation shows the relationship between Impact BioMedical, stock current value and its past values and can show if there is a momentum factor associated with investing in Impact BioMedical,.
Regressed Prices |
| Timeline |
Pair Trading with Impact BioMedical,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Impact BioMedical, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Impact BioMedical, will appreciate offsetting losses from the drop in the long position's value.Moving together with Impact Stock
Moving against Impact Stock
| 0.78 | VCYT | Veracyte | PairCorr |
| 0.77 | VCEL | Vericel Corp Ord | PairCorr |
| 0.73 | DNLI | Denali Therapeutics | PairCorr |
| 0.65 | VKTX | Viking Therapeutics | PairCorr |
| 0.64 | DNTH | Dianthus Therapeutics | PairCorr |
The ability to find closely correlated positions to Impact BioMedical, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Impact BioMedical, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Impact BioMedical, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Impact BioMedical, to buy it.
The correlation of Impact BioMedical, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Impact BioMedical, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Impact BioMedical, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Impact BioMedical, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Impact BioMedical, Correlation, Impact BioMedical, Volatility and Impact BioMedical, Alpha and Beta module to complement your research on Impact BioMedical,. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Impact BioMedical, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.